Loading portfolio…
Loading portfolio…
| # | Issuer | Value | Shares | % Portfolio |
|---|---|---|---|---|
| 1 | SPDR GOLD TR | $3.28B | 7623 | 81.50% |
| 2 | BERKSHIRE HATHAWAY INC DEL | $348.3M | 727 | 8.66% |
| 3 | KYVERNA THERAPEUTICS INC | $162.0M | 18773 | 4.03% |
| 4 | LEXEO THERAPEUTICS INC | $80.0M | 13943 | 1.99% |
| 5 | X4 PHARMACEUTICALS INC | $64.2M | 15557 | 1.60% |
| 6 | INHIBIKASE THERAPEUTICS INC | $47.8M | 28453 | 1.19% |
| 7 | ALX ONCOLOGY HLDGS INC | $42.0M | 20946 | 1.04% |
Values in USD (reported in $thousands on 13F). Source: SEC EDGAR.